Reviews
Introduction
For a number of hallucinogenic compounds which have appeared in the drug market in the last few years, scientifically sound and controlled literature data are lacking. This is especially true for a number of psychedelic drugs, including 2C-T-7 (2,5-dimethoxy-4-(n)-propylthiophenethylamine). Therefore, it is of potential value for future research in this area to collect together in a review the available clinical and pharmacological data on 2C-T-7 and the information on its use, both at the cyber and at the street market level.
2C-T-7: preclinical and clinical pharmacological issues
2C-T-7, first synthesized in 1986, is the most famous compound of a group of 24 phenethylamine homologues that show a wide and varied psychopharmacology (Totse, 2004) , with 2C-T-2, 2C-T-4 and 2C-T-7 (the S-ethyl, S-isopropyl and S-propyl) being both potent and LSD-like (Peyton and Shulgin, 1994) . 2C-T-7 is reported to have 15 times the mescaline potency (Peyton and Shulgin, 1994) . The 2C-T compounds have structural and pharmacodynamic properties similar to other phenethylamine hallucinogens, such as mescaline, MDMA (3,4methylenedioxymethamphetamine; 'ecstasy') and PMA (paramethoxyamphetamine) (Curtis et al., 2001) . According to Khorana et al. (2004) , however, 2C-T-7 seems best classified as a DOM [1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane]-like hallucinogen. The phenethylamine and indoleamine hallucinogens, despite differences in their chemical structure, display similar clinical effects and cross-tolerance in human studies (Balestrieri and Fontanari, 1959; Curtis et al., 2001) . There is an excellent correlation between the affinity of both indoleamine and phenethylamine hallucinogens for 5-HT2 and, to some degree, 5-HT1, receptors on the one hand and their hallucinogenic potency in humans on the other (Titeler et al., 1988; Glennon, 1990; European Monitoring Centre for Drugs and Drug Addiction, 2004) . More specifically, there is evidence from both biochemical (Sanders-Bush et al., 1988) and behavioural (Glennon, 1990; Marek and Aghajanian, 1996; Gewirtz and Marek, 2000) studies that both 5-TH2A and 5-TH2C receptors' subgroups, in both rodents and humans, are involved (Marek and Aghajanian, 1996; Vollenweider, 1998; Backstrom et al., 1999; Aghajanian and Marek, 1999) . At present, there are no animal or human data concerning general toxicity or neurotoxicity potential of 2C-T-7, which does not have any known medical or industrial use.
2C-T-7 is typically available as powder or tablet; its primary route of administration is oral, at a dosage of 10-30 mg. Insufflation (snorting) is also commonly mentioned in user reports. After oral ingestion, 2C-T-7 peak plasma levels are observed in about 1-2.5 h; its psychoactive effects may last up to 5-15 h. If 2C-T-7 is snorted, peak plasma levels may be reached quicker (Stolaroff and Wells, 1993; Hardison, 2000; Murple, 2001; European Monitoring Centre for Drugs and Drug Addiction, 2004) . It seems that 2C-T-7 may be excreted unchanged, with oxidative deamination being the main metabolic pathway (Murple, 2001) . A screening method for 2C-T-7, based on gas chromatography-mass spectrometry, has been recently developed (Vorce and Sklerov, 2004) .
2C-T-7 desired effects include both a sense of closeness to others (empathy) and a sense of well-being. Reported adverse effects include: visual/auditory hallucinations, nausea and vomiting, headache, hypertension, tachycardia, gastrointestinal disturbances, muscle tension, tremor, anxiety, panic attacks, paranoid ideation, memory disturbances and confusion (Stolaroff and Wells, 1993; Hardison, 2000; European Monitoring Centre for Drugs and Drug Addiction, 2004) .
Three deaths have been reported in the USA after 2C-T-7 snorting (Curtis et al., 2001) . In one case, 2C-T-7 was insufflated, at a dosage of 35 mg, on its own (Curtis et al., 2003) . In the remaining two cases, the compound was taken together with MDMA (European Monitoring Centre for Drugs and Drug Addiction, 2004) .
A number of MDMA-like compounds are controlled as Class A drugs in the UK. Most of them, including MDEA, 2C-I, 2C-T-2, 2C-T-7 and TMA-2, have been controlled since 1977 by a regulation which covers the generic phenethylamine structure. The compound is also controlled in all EU member states, in the USA and in Canada.
The 2C-T-7 European street market
2C-T-7 ('Blue Mystic') popularity started in 1997, when it became possible to purchase it from some German and Dutch 'smart shops'. De Boer et al. (2004) collected data related to phenethylamines of the 2C-series in Dutch smart shops during the period 1994-2002. All products that were claimed to contain synthetic drugs and sold in the premises were purchased. Most of the purchased products proved to contain one of the phenethylamine designer drugs 2C-B, 2C-T-2 or 2C-T-7. The availability of the compound at street level seems to be currently very low, notably in Europe. In December 2004, for the purpose of the present study, updated information on 2C-T-7 was sought from both the UK Forensic Science Service and National Criminal Intelligence Service, but nothing specifically related to it was reported to us. In the UK, a dance music magazine survey of nearly 500 respondents carried out in 2002 found no one had ever tried 2C-T-7, but an Internet survey of 2C-T-7 users obtained 423 valid responses from people who had taken 2C-T-7 (European Monitoring Centre for Drugs and Drug Addiction, 2004).
In the last few years, law enforcement agencies from different Member States have reported to Europol that there is no information available which would suggest large-scale production, distribution of and/or trafficking in 2C-T-7 or a role for organized crime in these activities ( 
The 2C-T-7 cyber market
Despite the paucity of both law enforcement and scientific reports regarding 2C-T-7 in the published literature, the situation is very different on the web, where information about this compound is 'just a click away' (Wax, 2002; Falck et al., 2004) . As a consequence, we aimed here at identifying and describing the information available online on 2C-T-7.
This survey, representing a special exercise of the Psychonaut 2002 Project (Schifano et al., 2003) , was carried out between October 2003 and January 2004. During this period, we searched the Internet with two of the most well-known search engines (i.e., Google™ and AltaVista™). To allow coverage of both the 2C-T-7 acronym and of its most usual street names (i.e., 'Blue Mystic' and 'Tripstacy'), a selection of different keywords and combinations of keywords including '2C-T' and 'MDMA-like' was chosen. The term '2C-T-7' was matched with a variety of other terms (i.e., 'buy', 'rave', 'recipe' and 'shop') as well, in order to get information on the possibility of purchasing the compound online. The first 100 websites identified by Google™ and AltaVista™ with the '2CT-7' term were fully assessed and, whenever this was available, a further random sample of 10 links offered by Google™ and 10 by AltaVista™ (chosen among the first 100 between those identified with the use of each of the other keywords) were assessed as well. For those websites which were written in languages different from English, the assessment was carried out with the help of professionals fluent in that specific language.
Survey data included: website relevance; ranking; country of origin; website aims; website position towards drug use; purchase possibilities. Ranking referred to the numerical order of presentation in the results' list of the search engine. In taking into account the index website position towards drug use, four main categories were identified: Anti Drugs; Pro Drugs; Harm Reduction Approach; Not Stated. An Anti Drugs website typically advocated against the use of any drugs. Most usually, either prevention and/or treatment information was offered in these websites. On the other hand, Pro Drugs websites were actively promoting or facilitating the use of drugs. Typically, they provided information on how to synthesize, purchase or consume a variety of substances. Harm Reduction websites neither condemned nor promoted the use of drugs; they aimed instead at presenting evidence and facts, giving the surfers/readers the possibility of drawing their own conclusions. If a doubt was arising with respect to the categorization of a specific website, an agreement was sought between FS, PD and the researcher.
In following the methodology above described, 360 websites were identified and thoroughly assessed. Due to a degree of redundancy both within and between search engines, this initial sample was reduced to 174 websites. Eventually, whilst taking into account the relevance of the identified websites, a second screening was performed and those websites which were referring to issues different from drugs (i.e., music; movies, etc.) were eliminated. These procedures further reduced the sample to 118 websites.
The keywords which elicited the highest rates of relevant results were: '2C-T-7' (88% of relevant results); '2C-T-7 ϩ rave' (80%); '2C-T-7 ϩ recipe' (67%) and 'MDMA-like' (58%). On the other hand, neither the 'MDMA' nor the 'Blue Mystic' keywords elicited any relevant results.
For 17 websites (14.4%) it was impossible to identify their country of origin; 47 websites (39.8%) turned out to be originating from the USA, whilst 7 websites (5.9%) were originating from each of the following countries: the UK, Germany and Japan.
Most websites were providing either general information or news pertaining to 2C-T-7 and almost 30% of websites reported personal or others' accounts of 2C-T-7 intake experience. In 14 (11.9%) websites, the detailed description of the 2C-T-7 process of synthesis was given.
With respect to the overall position of websites towards the use
The cyber and street market of recreational drugs 677 of drugs (see Table 1 ), it appeared that 26% of them did not clearly state their view, 27% had a Pro Drugs approach while there was almost a similar rate of Anti Drugs (24%) and Harm Reduction Approach (23%) websites. According to the one-way ANOVA results, the website ranking number differed significantly as a function of the website position towards the use of drugs (F (3, 114) ϭ 4.52, p Ͻ 0.005). The Tukey's HSD post hoc test revealed that Harm Reduction websites were ranking significantly lower than Anti Drugs (p ϭ 0.006) and Not Stated (p ϭ 0.017) websites. Finally, 5 (4.2%) websites were apparently offering the audience the possibility to purchase 2C-T-7, either through the use of a credit card or via a system which involved the use of e-mails.
Discussion
The present report constitutes a systematic overview of both literature and online available multilingual information on 2C-T-7. This compound appears to be the most famous of a group of hallucinogenic phenethylamines that have psychoactive properties and side effects somewhat similar to other recreational drugs, such as MDMA ('ecstasy').
Only a few scientific reports have been published on 2C-T-7 and one of the suggestions from the present overview is that a web mapping of drug-related issues might be of interest for the practising clinician. However, much of the material quoted here referring to web based sources was not evidence-based and, for this reason, has proved to be difficult indeed to critically evaluate. The technical knowledge on new products entering the market, hardly obtained through reference books and scientific journals, is often held in closed groups of users, who exchange information with each other without any contact with the scientific world. To a certain extent, web browsing has become a sort of social system, which assembles people with similar interests and habits (Riva, 2001) .
According to the survey results given here, 2C-T-7 was perceived on the web to be within the group of the MDMA-like substances, with almost 60% of relevant websites identified with this keyword. This seems to suggest the existence of similarities and/or of a certain degree of overlapping between the much larger population of MDMA and that of 2C-T-7 users. On the other hand, many people are led to believe that alternative hallucinogenic phenethylamines, including 2C-T-7, are a form of 'legal' ecstasy or LSD (Drug Enforcement Administration, 2004) .
A large quantity of personal advice and suggestions with respect to 2C-T-7 dosage, best ways of experimenting with its effects and avoiding untoward reactions was available in about 30% of the websites we sampled. The appeal of the Internet for those experimenting with hallucinogenic compounds (Falck et al., 2004) can explain why, over the past few years, the psychoactive research chemical market has grown to the point that many of the vendors have been advertising on major search engines. We were able here to identify a number of websites offering 2C-T-7 for sale and it is of interest that the recent US drug enforcement 'Operation Web Tryp' found that products sold by the websites they identified were synthetic substances, including phenethylamines (Drug Enforcement Administration, 2004) . Falck et al. (2004) found that Harm Reduction websites were visited by four times as many users as government-sponsored websites by ecstasy users. Our findings seem to further shed light on this issue, since it appears that those websites which gave information and advice on how to best plan the drug intake experience (like the Harm Reduction and Pro Drugs websites) appeared earlier in the search engines' list than the governmental/prevention/Anti Drugs websites. In other words, information on 2C-T-7 of possible concern for at-risk and vulnerable users was more readily and promptly accessible on the web. Our findings seem to support the idea that projects aimed at designing more 'attractive', vigorously advertised, prevention websites should be implemented.
The large body of knowledge, albeit mostly anecdotal, which is offered online seems to contrast with the small numbers of seizures at street level, at least in the EU. One could wonder if lack of reported seizures is a convincing demonstration that the compound is not actually available. In our opinion this may be challenged, since the cyber and street markets may have different characteristics (Schifano et al., 2003) . The operational procedures of the law enforcement agencies, traditionally oriented to restricting the street market, might not be effective enough in monitoring the cyber market. The limited number of observed intoxications, whilst it may well be the consequence of the small amount of 2C-T-7 available, may be explained as well by either the inability of toxicologists to detect the abuse of substances of the 2C-series or by the unawareness of the phenomenon of these drugs.
One could argue that neither the online existence of lively discussion on 2C-T-7 nor its apparent purchase possibilities are, per se, a demonstration of its use. We did not survey here the actual use of the online information by interested web surfers, but only the availability and the content of data on 2C-T-7. On the other hand, it has been estimated that the hallucinogenic phenethylamines cyber market profits are possibly in the region of 20 000 US dollars per week (Drug Enforcement Administration, 2004) . Future studies should better assess the characteristics of those consumers who take advantage of the online available information on hallucinogenic compounds; the stereotypical image of the 'drug misuser' may need to change (Littlejohn et al., 2005) .
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